Market revenue in 2023 | USD 107.4 million |
Market revenue in 2030 | USD 502.2 million |
Growth rate | 24.6% (CAGR from 2023 to 2030) |
Largest segment | Software |
Fastest growing segment | Software |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Software, Hardware, Services |
Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 44.04% in 2023. Horizon Databook has segmented the North America artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Major factors contributing to the growth of this region are local presence of major market players, growing cancer prevalence, increasing patient awareness, growing digital infrastructure, rising number of government initiatives, and growing awareness about the use of AI in cancer diagnostics.
For instance, in March 2019, the U.S. government launched a new website called AI.gov, which is dedicated to presenting ideas regarding development, regulation, and application of AI in the U.S. The website was allowed to be used after the U.S. President Donald Trump signed an official order describing AI policy.
Increasing adoption of Artificial Intelligence (AI) in cancer diagnosis and increasing investment in AI healthcare startups are factors expected to drive North America’s AI in cancer diagnostics market. In addition, growing demand for reducing diagnostic costs, improving patient care, and reducing machine downtime are further accelerating usage of AI in diagnostics.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account